Society of Nuclear Medicine and Molecular Imaging (SNMMI)

In the December Issue of The Journal of Nuclear Medicine

Current Status of Reactors Producing Mo-99

CTN: Enabling Accurate Quantitative PET/CT and SPECT/CT Imaging

SNMMI/LBCA Announce $100,000 Research Grant

In December JNM: A discussion with GU oncologist Declan Murphy … The State of the Art: FAPI PET/CT in nonmalignant diseases … Continuing Education: FDA approval for theranostic agents … Focus on MI: Nanoparticle diagnostics and theranostics … Featured: a-Particle and immunocytokine therapy … Cardiac amyloidosis in bone scan referrals … and more.

There will be a shortfall in Mo-99 production and hence a shortage of Mo-99/Tc-99m generators through late November of this year. Check the Advocacy/Radiopharmaceutical Supply News page on the SNMMI website for the latest updates.

There is renewed urgency for quantitative measurements, which have long been a strength of nuclear medicine. The SNMMI Clinical Trials Network continues to be involved in this space, with several active projects to address this need.

SNMMI is excited to announce the release of the new MIRD Primer 2022: A Complete Guide to Radiopharmaceutical Dosimetry—a comprehensive, state-of-the-art guide to radiopharmaceutical dosimetry that reflects the dramatic evolution of the field of nuclear medicine, including molecular imaging and, increasingly, radiopharmaceutical therapy. Purchase your copy.

In honor of Nuclear Medicine & Molecular Week and Breast Cancer Awareness Month, SNMMI and the Lobular Breast Cancer Alliance are excited to announce a $100,000 Invasive Lobular Carcinoma Imaging Research Grant as part of the new SNMMI Mars Shot Fund. Learn more about this grant and submit an application.

SNMMI NEWS

December 1, 2022 — This Month in JNM
In December JNM: A discussion with GU oncologist Declan Murphy … The State of the Art: FAPI PET/CT in nonmalignant diseases … Continuing Education: FDA approval for theranostic agents … Focus on MI: Nanoparticle diagnostics and theranostics … Featured: a-Particle and immunocytokine therapy … Cardiac amyloidosis in bone scan referrals … and more. (SNMMI News)
November 22, 2022 — CMS Publishes 2023 MPFS and Hospital OPPS Final Rule
On November 1, CMS released the 2023 Medicare Physician Fee Schedule and Hospital Outpatient Prospective payment Final Rules. (Government Relations News)
November 17, 2022 — Novel PET Agent Effectively Detects Multiple Cancers, Identifies Patients for Targeted Therapies
A new molecular imaging radiotracer, Ga-68 PentixaFor, can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. (Press Releases)
November 16, 2022 — SNMMI Announces Ones to Watch 2022 Selections
SNMMI is pleased to present our annual list of 30 early career professionals selected as “Ones to Watch” in 2022! (SNMMI News)
November 16, 2022 — 2023 Ones to Watch Nominations
SNMMI is now accepting nominations for our 2023 Ones to Watch selections. We need your help in identifying and recognizing “ones to watch” in the coming years, as they work to shape the future of nuclear medicine and molecular imaging. Members can nominate someone they know—currently in training or who have completed their training within the last 10 years—whose actions, work, or studies have set them apart as a future thought leader in the field. (SNMMI News)
November 10, 2022 — PET/MRI Machine Learning Model Can Eliminate Sentinel Lymph Node Biopsy in Majority of Breast Cancer Patients
Nearly 70 percent of breast cancer patients could find out if their cancer has spread to their lymph nodes without having to undergo an invasive sentinel node biopsy, according to new research published in JNM. (Press Releases)
October 31, 2022 — Mo-99/Tc-99m shortage expected to impact provider care and limit patient access
Nuclear Medicine Europe has reported a shortage of Molybdenum-99 (Mo-99)/Technetium-99m (T-99m). (Government Relations News)
October 27, 2022 — Pomper Wins Minnie’s 2022 Most Influential Radiology Influencer for F-18 DCFPyL
Martin Pomper, MD, PhD, has been named Most Influential Radiology Researcher for 2022 by AuntMinnie for his work in developing F-18 DCFPyL. (SNMMI News)

CONTINUING EDUCATION

New! ASNC/SNMMI 80 Hour Authorized User Training Course

The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »

New! SNMMI Qualified Systems Personnel Training Program (QSPTP)

The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »

SNMMI Webinars

Access upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »

Nuclear Medicine Online Review Course

Covering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »

Radiation Safety+ Review and Essentials

The Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »

CT+ Review and Essentials

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »

Member Benefit! Complimentary Journal SAMs/Journal CE

Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »

PUBLICATIONS

Journal of Nuclear Medicine

VIEW CURRENT ISSUE
Journal of Nuclear Medicine Technology

VIEW CURRENT ISSUE
Molecular Imaging
Journal

VIEW CURRENT ISSUE

FEDERAL LEGISLATIVE EFFORTS

The FIND Act – Learn more »

MOLECULAR IMAGING NEWS

December 2, 2022

EDUCATION AND RESEARCH FOUNDATION

ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »